Genfit SA Profile

USD 0.10  0.32%

Genfit SA Summary

Genfit SA (GNFTF) is traded on OTC Market in USA. It is located in Parc Eurasant? and employs 125 people. The company currently falls under 'Small-Cap' category with current market capitalization of 968.12 M. Genfit SA has 31.17 M outstanding shares. GENEFIT has accumulated about 336.75 M in cash with (61.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.81.
Check Genfit SA Probability Of Bankruptcy

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 72.42%30 days 31.10  about 27.51%
Based on normal probability distribution, the odds of Genfit SA to move above current price in 30 days from now is about 27.51% (This Genfit SA probability density function shows the probability of Genfit SA Stock to fall within a particular range of prices over 30 days) .

Genfit SA Risk Profiles

Key Fundamentals

Genfit SA Against Markets

Current Ratings

Genfit SA 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 39% 
Equity ratings for Genfit SA are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Genfit SA, a biopharmaceutical company, develops therapeutic and diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver worldwide. Genfit SA was founded in 1999 and is headquartered in Loos, France. Genfit SA is traded on OTC Market in USA. more
NameGenfit SA
ChairmanCharles WolerView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressParc Eurasant?
ExchangeOTC Market
Contact Number33 3 20 16 40 00
CurrencyUSD - US Dollar

Diversify with Genfit SA

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Genfit SA to your portfolio


Genfit SA Corporate Management
Florence Sejourne Member of the Supervisory Board, Representative of Biotech Avenir
Frederic Desdouits Member of the Supervisory Board
Nathalie Huitorel Chief Financial and Admin. Officer and Member of The Executive Board
Philippe Moons Member of the Supervisory Board, Representative of Finorpa
Please also check Risk vs Return Analysis. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.